A carregar...
SAT1 and glioblastoma multiforme: Disarming the resistance
Glioblastoma multiforme is the most common and most detrimental form of brain tumor, with a current survival time of as little as 14 months. We have recently identified a novel mechanism of therapeutic resistance based on overexpression of the polyamine catabolic enzyme spermidine/spermine N1-acetyl...
Na minha lista:
Publicado no: | Mol Cell Oncol |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905296/ https://ncbi.nlm.nih.gov/pubmed/27308461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723556.2014.983393 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|